Case Reports
7 May 2025
Vol. 19 No. 2 (2025)
Pulmonary nodules in rheumatoid arthritis: the case of leflunomide
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
372
Views
129
Downloads
15
HTML
Authors
Rheumatoid arthritis (RA) is a chronic autoimmune disease primarily affecting joints. Extra-articular manifestations, including pulmonary involvement, significantly contribute to morbidity and mortality. Disease-modifying antirheumatic drugs are crucial for RA treatment but may also have pulmonary side effects. The differentiation between pulmonary RA manifestations, infection in the immunosuppressed patient, and drug-induced pulmonary toxicity remains a diagnostic and therapeutic challenge. This report presents a rare case of accelerated pulmonary nodulosis associated with leflunomide therapy, emphasizing the need for careful differential diagnosis in immunosuppressed patients.
Altmetrics
Downloads
Download data is not yet available.
Citations
Cross M, Smith E, Hoy D, et al. The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis 2014;73:1316-22. DOI: https://doi.org/10.1136/annrheumdis-2013-204627
Tashfeen M, Jose C, Isham I, Kenneth N. The effect of disease modifying drugs on the lung in patients with rheumatoid arthritis. Southwest Respir Crit Care Chron 2016;4:3-11. DOI: https://doi.org/10.12746/swrccc2016.0413.166
Spagnolo P, Lee JS, Sverzellati N, et al. The lung in rheumatoid arthritis: focus on interstitial lung disease. Arthritis Rheumatol. 2018;70(10):1544-54. DOI: https://doi.org/10.1002/art.40574
ARAVA® (leflunomide) prescribing information. Bridgewater, NJ: Sanofi-Aventis; 2010. Food and Drug Administration. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020905s020lbl.pdf.
Wong SPY, Chu CM, Kan CH, et al. Successful treatment of leflunomide-induced acute pneumonitis with cholestyramine wash-out therapy. J Clin Rheumatol 2009;15:389-92. DOI: https://doi.org/10.1097/RHU.0b013e3181c3f87e
Skeoch S, Weatherley N, Swift AJ, et al. Drug-induced interstitial lung disease: a systematic review. J Clin Med 2018;7:356. DOI: https://doi.org/10.3390/jcm7100356
Lacoste-Palasset T, Chaumais MC, Weatherald J, et al. Association between Leflunomide and Pulmonary Hypertension. Ann Am Thorac Soc 2021;18:1306-15. DOI: https://doi.org/10.1183/13993003.congress-2021.OA146
Martin N, Innes JA, Lambert CM, et al. Hypersensitivity pneumonitis associated with leflunomide therapy. J Rheumatol 2007;34:1934-7.
Raj R, Nugent K. Leflunomide-induced interstitial lung disease: a systematic review. Sarcoidosis Vasc Diffuse Lung Dis 2013;30:167-76.
Sakai F, Noma S, Kurihara Y, et al. Leflunomide-related lung injury in patients with rheumatoid arthritis: imaging features. Mod Rheumatol 2005;15:173-9. DOI: https://doi.org/10.1007/s10165-005-0387-9
Rozin A, Yigla M, Guralnik L, et al. Rheumatoid lung nodulosis and osteopathy associated with leflunomide therapy. Clin Rheumatol 2006;25:384-8. DOI: https://doi.org/10.1007/s10067-005-0024-1
Abiyarghamsari M, Ahmadzadeh A. Pulmonary nodules after leflunomide therapy in rheumatoid arthritis: a case report. Clin Case Rep 2024;13:e9615. DOI: https://doi.org/10.1002/ccr3.9615
Karadag F, Polatli M, Senturk T, et al. Cavitary necrobiotic nodule imitating malignant lung disease in a patient without articular manifestations of rheumatoid arthritis. J Clin Rheumatol 2003;9:246-52. DOI: https://doi.org/10.1097/01.rhu.0000081260.50171.bf
McCurry J. Japan deaths spark concerns over arthritis drug. Lancet 2004;363:461. DOI: https://doi.org/10.1016/S0140-6736(04)15527-X
Suissa S, Hudson M, Ernst P. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. Arthritis Rheum 2006;54:1435-9. DOI: https://doi.org/10.1002/art.21806
Braun MG, van Rhee R, Becker-Capeller D. Neuauftreten und/oder Zunahme von Rheumaknoten unter Leflunomidtherapie bei RA-Patienten. Z Rheumatol 2004;63:84-7. DOI: https://doi.org/10.1007/s00393-004-0537-z
Grisar J. Leflunomide inhibits transendothelial migration of peripheral blood mononuclear cells. Ann Rheum Dis 2004;63:1632-7. DOI: https://doi.org/10.1136/ard.2003.018440
How to Cite
Pulmonary nodules in rheumatoid arthritis: the case of leflunomide. (2025). Italian Journal of Medicine, 19(2). https://doi.org/10.4081/itjm.2025.1964
Copyright (c) 2025 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Riccardo Gerloni, Luciano Mucci, Carlotta Casati, Andrea Crociani, Ombretta Para, Elisabetta Benetti, Paola Gnerre, Anna Bovero, Elisa Romagnoli, Nicola Tarquinio, Clelia Canale, Davide Brancato, Laura Massarelli, Salvatora Piras, Management of sepsis: from evidence to clinical practice , Italian Journal of Medicine: Vol. 10 No. 4 (2016)
- Domenico Galasso, Giovanni Forte, Norma Marigliano, Focus on the spondyloarthritides. Can earlier diagnosis change the course of the disease? , Italian Journal of Medicine: Vol. 4 No. 4 (2010)
- Domenico Galasso, Massimo L'Andolina, Norma M. Marigliano, Salvatore Galasso, Giovanni Forte, Clinimetric criteria of rheumatoid arthritis , Italian Journal of Medicine: Vol. 6 No. 3 (2012)
- Livio Bonsignore, Roberto Cardillo, Salvatore Leotta, Sebastiano Pavone, Alfonsa Lucia Dimora, Irene Alfina Cavallaro, Rosaria Platania, Nunzio Maurizio Catania, Rocco Siciliano, Adult onset Still's disease: a comparison of two clinical cases , Italian Journal of Medicine: Vol. 7 No. 4 (2013)
- Alain Kafyeke, Giovanni Pomponio, Andrea Balloni, Simona Gambini, Francesca Barbisan, Armando Gabrielli, Asymptomatic endoalveolar hemorrhage in a young male , Italian Journal of Medicine: Vol. 10 No. 2 (2016)
- Flavio Tangianu, Paola Gnerre, Fabrizio Colombo, Roberto Frediani, Giuliano Pinna, Franco Berti, Giovanni Mathieu, Micaela La Regina, Francesco Orlandini, Antonino Mazzone, Clelia Canale, Daniele Borioni, Roberto Nardi, Could clustering of comorbidities be useful for better defining the internal medicine patients' complexity? , Italian Journal of Medicine: Vol. 12 No. 2 (2018)
- Giuseppe Brunori, Aurelio Seidita, Lydia Giannitrapani, Antonietta Serruto, Francesco Bencivinni, Maurizio Soresi, An unusual Erdheim-Chester disease with orbital involvement: a case report , Italian Journal of Medicine: Vol. 11 No. 1 (2017)
- Andrea Montagnani, Roberto Nardi, Michela Cercignani, Valerio Verdiani, Potential role of vitamin D in prevention of skeletal and extraskeletal diseases in older people , Italian Journal of Medicine: Vol. 10 No. 1 (2016)
- P120 | Tumourlets and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a rare cause of Cushing syndrome , Italian Journal of Medicine: Vol. 19 No. 1(s1) (2025): XXX FADOI Italian Congress | 10-12 May 2025
- Rrezarta Alihajdaraj, Ergeta Ktona, Blerta Budani, Jehona Ismaili Kadriaj, The impact of tocilizumab on hepatic enzyme levels in rheumatoid arthritis patients: a narrative review , Italian Journal of Medicine: Early Access
You may also start an advanced similarity search for this article.